BRAF and melanoma: Strikingly, Tan et al. showed that BRAF-mutated melanoma cell lines were more susceptible to the apoptotic effects of BRAF and MEK inhibitors when they carried a TERT promoter mutation compared to cell lines with wild-type TERT [7].